Nuclear receptors - target molecules for isoflavones in cancer chemoprevention

Lucia Bialešová1, Július Brtko, Vladimír Lenko

  • 1Laboratory of Molecular Endocrinology, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic. ueenmace@savba.sk.

Insights

This study explores isoflavones, natural compounds found in soy, as potential treatments for breast cancer. Research into these estrogen receptor ligands offers new avenues for breast cancer therapy.

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Breast cancer is a leading cancer in women, with high treatment costs and variable effectiveness.
  • Nuclear receptors are key targets for improving breast cancer treatment strategies.
  • Isoflavones, natural compounds structurally similar to 17β-estradiol, are ligands for estrogen receptors (ERα and ERβ).

Purpose of the Study:

  • To investigate the potential of isoflavones as alternative or supplementary treatments for breast cancer.
  • To highlight the role of nuclear receptors, specifically estrogen receptors, in breast cancer therapy.
  • To identify natural sources and key types of isoflavones relevant to breast cancer research.

Main Methods:

  • Literature review on isoflavones and their interaction with estrogen receptors.
  • Analysis of isoflavone structures and their similarity to 17β-estradiol.
  • Identification of natural sources rich in isoflavones, such as soy and red clover.

Main Results:

  • Isoflavones, including genistein, daidzein, glycitein, biochanin A, and formononetin, are found in soy and red clover.
  • These compounds act as natural ligands for estrogen receptors (ERα and ERβ).
  • Their structural similarity to 17β-estradiol suggests potential endocrine activity relevant to breast cancer.

Conclusions:

  • Isoflavones represent a promising area for developing novel breast cancer treatments.
  • Targeting nuclear receptors with natural ligands like isoflavones could enhance therapeutic opportunities.
  • Further research into isoflavones may lead to more effective and less burdensome breast cancer therapies.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...